Background: Long-Interspersed Nuclear Element (L1) retrotransposons are silenced in healthy tissues but unrepressed in cancer. Even if L1 reactivation has been associated with reduced overall survival in breast cancer (BC) patients, a comprehensive correlation with clinicopathological features is still missing. Methods: Using quantitative, reverse-transcription PCR, we assessed L1 mRNA expression in 12 BC cells, 210 BC patients and in 47 normal mammary tissues. L1 expression was then correlated with molecular and clinicopathological data. Results: We identified a tumor-exclusive expression of L1s, absent in normal mammary cells and tissues. A positive correlation between L1 expression and tumor dedifferentiation, lymph-node involvement and increased immune infiltration was detected. Molecular subtyping highlighted an enrichment of L1s in basal-like cells and cancers. By exploring disease-free survival, we identified L1 overexpression as an independent biomarker for patients with a high risk of recurrence in hormone-receptor-negative BCs. Conclusions: Overall, L1 reactivation identified BCs with aggressive features and patients with a worse clinical fate.

The Tumor-Specific Expression of L1 Retrotransposons Independently Correlates with Time to Relapse in Hormone-Negative Breast Cancer Patients

Berrino, Enrico
First
;
Bellomo, Sara Erika;Debernardi, Carla;Bragoni, Alberto;Petrelli, Annalisa;Cascardi, Eliano;Giordano, Silvia;Marchio', Caterina;Venesio, Tiziana;Sapino, Anna
2022-01-01

Abstract

Background: Long-Interspersed Nuclear Element (L1) retrotransposons are silenced in healthy tissues but unrepressed in cancer. Even if L1 reactivation has been associated with reduced overall survival in breast cancer (BC) patients, a comprehensive correlation with clinicopathological features is still missing. Methods: Using quantitative, reverse-transcription PCR, we assessed L1 mRNA expression in 12 BC cells, 210 BC patients and in 47 normal mammary tissues. L1 expression was then correlated with molecular and clinicopathological data. Results: We identified a tumor-exclusive expression of L1s, absent in normal mammary cells and tissues. A positive correlation between L1 expression and tumor dedifferentiation, lymph-node involvement and increased immune infiltration was detected. Molecular subtyping highlighted an enrichment of L1s in basal-like cells and cancers. By exploring disease-free survival, we identified L1 overexpression as an independent biomarker for patients with a high risk of recurrence in hormone-receptor-negative BCs. Conclusions: Overall, L1 reactivation identified BCs with aggressive features and patients with a worse clinical fate.
2022
11
1944
1
15
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221920/
L1 retrotransposons; basal-like; breast cancer; tumor-exclusive biomarker; B7-H1 Antigen; Hormones; Humans; Neoplasm Recurrence, Local; Retroelements; Triple Negative Breast Neoplasms
Berrino, Enrico; Miglio, Umberto; Bellomo, Sara Erika; Debernardi, Carla; Bragoni, Alberto; Petrelli, Annalisa; Cascardi, Eliano; Giordano, Silvia; Montemurro, Filippo; Marchio', Caterina; Venesio, Tiziana; Sapino, Anna
File in questo prodotto:
File Dimensione Formato  
cells_11-01944.pdf

Accesso aperto

Tipo di file: PDF EDITORIALE
Dimensione 317.65 kB
Formato Adobe PDF
317.65 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1879181
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
social impact